Age distribution of abnormal pap smear in a secondary hospital in south-west Nigeria by Osasan, SA et al.
63
Trop J Obstet Gynaecol, 31 (2), August 2014
Cervical cancer is the second most common 
cancer in women worldwide and the leading 
cause of cancer deaths among women in 
developing countries. It is particularly prevalent 
in Sub-Saharan Africa and is associated with a 
1,2 3high mortality rate . The disparity in this 
disease burden between developed and 
developing countries is attributable to the 
organized screening programmes in developed 
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Background: Cervical cancer is a leading cause of cancer death in Sub- Saharan Africa. It is the second 
commonest cancer in women worldwide. The prevalence of the disease has reduced in developed nations 
compared to most developing nations as a result of systematic screening programmes. There is no age 
distribution pattern of abnormal Paps smear in Nigerian women today that can help in the design of a 
national screening programme.
Objective: To determine the age distribution pattern of abnormal Paps smear in women in our environment 
in order to have a basis for the points of entry and exit for cervical cancer screening protocol.  
Materials and Method: In this retrospective review, the 102 clients who had abnormal smear out of the 
total  629 clients who had Pap's smear at the State Specialist Hospital, Akure over a period of 5years (2008-
2012) were analyzed for specific diagnosis and their age distribution.
Results: Among the clients with abnormal smear, 57 (55.9%) had ASCUS, 34 (33.3%) had LSIL and 9 
(8.8%) of the clients had HSIL. A client each had AGCUS and cancer cytology and was 50 and 60 years old 
respectively. ASCUS, LSIL and HSIL were found across all age groups except 30years and below where 
few LSIL were seen.
Conclusion: Screening uptake is still low in our environment and because only few LSIL were seen in 
Clients ≤30years, it may be cost effective to start screening from 30years and to exit screening at 70years 
since abnormal smears were still found in women ≥70years.
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INTRODUCTION
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nations for the detection of premalignant lesions 
of the cervix, early diagnosis of cervical cancer, 
treatment and adequate follow-up of detected 
4, 5cases . According to the WHO, Nigeria has a 
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population of 40.43 million women ages 15 
years and older who are at risk of developing 
cervical cancer. It is estimated that every year 
14,550 women would be diagnosed with 
cervical cancer and 9,659 of them would die 
from the disease in Nigeria. The World Health 
Organization also projects a 25% increase in 
incidence in the next decade in the absence of 
6
widespread interventions .
Cervical cancer unlike most other cancers offers 
great potential for prevention, early detection, 
and cure due to its long preinvasive phase. This 
cancer arises by four steps. These include human 
papilloma virus (HPV) infection, viral 
persistence, progression of clone of persistently 
infected cells to precancer and invasion. The 
whole of this process takes between 10-15 years. 
The backward steps occur also, namely 
clearance of HPV infection and the less 
frequently, regression of precancer to 
7
normalcy . The precancerous stage in this 
process is seen on cytology as abnormal Pap's 
smear. The repeated HPV infection phase is 
commoner in sexually active young adults, but 
interestingly reversal is the norm in most 
instances. Therefore all forms of screenings 
become significant after the age of thirty when 
persistence may be seen or in those less than 
7
thirty with immunosuppression . 
At the moment three modalities of screening are 
available. These are the Pap's smear or 
conventional cytology, visual inspection aided 
with Acetic Acid (VIA) and high risk HPV DNA 
testing. Pap's smear has been the main stay of 
screening for cervical precancer in all developed 
countries. It has high specificity but low 
5
sensitivity . The VIA has been proposed for 
resource poor countries where no systematic 
6
screening exists . This method is low in 
sensitivity and specificity. The HPV DNA test is 
7
highly specific and equally sensitive . Most 
screening protocols now have the high risk HPV 
screening tests as part of their components to 
8
improve the overall specificity and sensitivity .
Though several terminologies have been used in 
the past in reporting abnormal Pap's smear, the 
need for terminologies that convey clear 
diagnostic interpretation of morphologic 
findings led to the Bethesda system of reporting. 
The 2001 revised Bethesda system basically 
partitioned premalignant cells into low grade 
(LSIL) and high grade squamous intraepithelial 
lesions (HSIL) with the description of some of 
atypias that do not fall under these broad bands 
as atypical squamous cells of undetermined 
significance (ASCUS) and atypical squamous 
cells, high grade lesion cannot be ruled out 
(ASC-H). All benign cellular changes and 
reactive processes are currently reported as 
negative for intraepithelial lesion or malignancy 
(NILM). When abnormal glandular cell 
components are seen they are described as 
atypical glandular cells of undetermined 
significance (AGCUS) or atypical glandular 
cells, high grade lesions cannot be ruled out 
9
(AGC-H) .     
An age distribution pattern of the various 
diagnosis of the precancer may help in 
developing a programme of screening that 
addresses the specific needs and peculiarity of 
our population.
MATERIALS AND METHODS
A retrospective review of all the cervical Pap 
smear cases reported at the department of 
Histopathology of the state specialist hospital 
Akure, South west Nigeria for a period of five 
years from January 2008 to December 2012 was 
done. All the cases were reported according to 
the  rev ised  2001  Bethesda  sys tem.  
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Unsatisfactory smears were excluded from the 
study.  The analysis of the data was done using 
SPSS 16.0.   
RESULTS
A total of 629 pap smears were reported during 
the period under review and 102 of them 
(16.3%) had abnormal cytology, 1 had 
malignant lesion while 527 of the clients 
representing 83.8% had cytology negative for 
Intraepithelial Lesion or malignancy (NILM) 
(Table 1).
 The mean age of clients with abnormal cytology 
were 53.5years with the youngest being 28 years 
and the oldest 80 years. Among the clients with 
abnormal smear, 57 (55.9%) had ASCUS, 34 
(33.3%) had LSIL and 9 (8.8%) of the clients 
had HSIL. A client each had AGCUS and cancer 
cytology and was 50 and 60 years old 
respectively (Table 2).  
The distribution of abnormal lesion across age 
group showed that ASCUS was present across 
all age groups except 30years and below with a 
peak at 51-60years. LSIL also spanned across all 
age groups with a similar peak as ASCUS. HSIL 
has a similar pattern also with ASCUS but with 
its own little peak at 61-70 years. A case each 
with AGC and malignancy was seen at 41-50 
years and 51-60 years. ASCUS, LSIL and HSIL 
were also seen in ≥71years group (Table 3, Fig 
1). 
Table 2: Diagnosis
Table 1: Classification of All Clients 




Precancer(ASCUS, LSIL, HSIL)  101(16.1%)
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Figure 1
DISCUSSION
In the five years period under review, only 629 
clients presented to the hospital for cervical 
cancer screening, in an environment where there 
is no systematic screening programme. This 
implies that the awareness of the public health 
importance of this disease is still low in our 
region. This equally accounts for the late 
presentation and high mortality associated with 
10
the disease .
The 102 abnormal smears seen in this review 
represents a prevalence of 16.3%. This is high 
compared to the prevalence reported in other 
 11
places like Kuwait  (4.3%) , Saudi Arabia 
12 13
(5%) , among Jewish Israeli women (0.95%)  
but comparable to those of American Indian 
14
(16%) and Alaska native women(14.9%) . The 
relatively higher prevalence in this study can be 
explained by the lack of an organized cervical 
screening programme for women in Nigeria 
compared with places where there are organized 
screening. In cases of the American Indians and 
Alaska native women whose prevalence were 
similar to that in this review, they represent a 
segment of the American population whose 
uptake of screening services is poor. 
This study shows ASCUS as the most 
preponderant lesion across all age groups, 
representing 55.9% of all abnormal lesions. This 
proportion is high considering the amorphous 
significance of this group. ASCUS has been 
shown in other studies to have histological 
correlations varying from reactive changes to 
15frank cancer . Dvorak et al reported 72% of 249 
ASCUS cases as histological cancer whereas 
Fallani et al reported only one ASCUS case as 
16, 17histological cancer in their own series . This 
therefore underscores the need for the further 
colposcopic evaluation of patients with ASCUS.   
Following ASCUS closely is LSIL (33.3%), 
HSIL (8.8%), AGCUS (1%) and invasive cancer 
(1%). This pattern is similar to that reported by 
18Edelman et al . 
Only few LSIL were found in clients 30years or 
less, those older had more of ASCUS, LSIL and 
HSIL in decreasing order. This pattern shows 
that abnormal smears are fewer below the age of 
30years and when they are found it is usually the 
low grade lesion which has the highest reversal 
tendency. The implication of this for planning a 
cervical cancer screening programme in our 
region is that it would be cost effective for 
screening to commence at 30years. Interestingly 
too, some abnormal lesions were found in 
women 70years and above. This correlates with 
findings in local studies demonstrating the 
persistence of high risk Human Papilloma Virus, 
the causative agent for cervical cancer in women 
19,20beyond 60years . This also implies that 
compared to most screening protocols that stop 
at the age of 60years, protocols in this part of the 
world may have to extend to the age of 70years. 
 
CONCLUSION
The uptake of cervical cancer screening is still 
very low in our environment as only women 
who come to the hospital for other reasons 
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undertake opportunistic screening. The 
prevalence of abnormal smear is high because 
of lack of systematic cervical cancer screening. 
Most lesions were seen after the age of 30years 
with significant lesions even in women 70years 
and above. There is therefore the need for a 
systematic cervical cancer screening 
programme in Nigeria that will be compulsory 
for women 30years or more with possible exit at 
the age of 70years.   
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